InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+143.7%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by PLATT DAVID, Chairman & CEO. Officer active across 1 company, notably Bioxytran, INC. In total, 22 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €180k. Activity tracked since 4 June 2021. The latest transaction was disclosed on 25 October 2024 (J). Regulator: SEC (Form 4). All data is free.
Declarations22 total
14,085,410 shares@ US$0.28523.9% of flowPreferredSEC:0001754429-24-000013:0
1,592,921 shares@ US$0.1241.2% of flowcommonSEC:0001754429-24-000004:0
Ideal exit: 12 May 2025 (T+270)
21,675,939 shares@ US$0.16220.4% of flowcommonSEC:0001754429-24-000004:1
4,335,188 shares@ US$0.80620.3% of flowpreferredSEC:0001754429-24-000004:2
8,973,405 shares@ US$0.0180.9% of flowpreferredSEC:0001754429-24-000004:3
776,817 shares@ US$0.4562.1% of flowpreferredSEC:0001754429-24-000004:4
411,300 shares@ US$0.0010.0% of flowcommonSEC:0001754429-24-000004:5
82,260 shares@ US$0.0050.0% of flowpreferredSEC:0001754429-24-000004:6
43,027,274 shares@ US$0.0010.2% of flowcommonSEC:0001754429-24-000004:7
8,605,455 shares@ US$0.0050.2% of flowpreferredSEC:0001754429-24-000004:8
439,595 shares@ US$0.1040.3% of flowcommonSEC:0001445815-24-000007:0
3,599,289 shares@ US$0.1352.9% of flowcommon stockSEC:0001445815-24-000002:0
5,824,741 shares@ US$0.1354.8% of flowcommonSEC:0001445815-23-000019:0
500,000 shares@ US$0.320.9% of flowcommon stockSEC:0001445815-23-000018:0
92,000 shares@ US$0.320.2% of flowcommonSEC:0001445815-23-000013:0
6,763,562 shares@ US$0.3212.6% of flowcommonSEC:0001166440-23-000001:0
411,300 shares@ US$0.0030.0% of flowcommonSEC:0001445815-23-000005:0
455,669 shares@ US$0.0010.0% of flowCommon stockSEC:0001166441-22-000002:0
3,201,788 shares@ US$0.13810.39% mcap27.5% of flowCommonSEC:0001539497-22-000081:0
3,201,788 shares@ US$0.13810.39% mcap54.9% of flowCommonSEC:0001539497-22-000081
2,973,988 shares@ US$0.138.52% mcap22.5% of flowCommonSEC:0001539497-21-000793:0
2,973,988 shares@ US$0.132.1% of flowCommonSEC:0001539497-21-000793
22 of 22 declarations
About PLATT DAVID
David Platt is CEO of Bioxytran, Inc. He leads the company with a strategic vision, overseeing all operations and ensuring performance objectives are met. His leadership is essential for the development of Bioxytran in the biotechnology sector.
